Literature DB >> 19047498

No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.

G Neri, J Allanson, M I Kavamura.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 19047498     DOI: 10.1136/jmg.2008.063263

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

2.  The face of Noonan syndrome: Does phenotype predict genotype.

Authors:  Judith E Allanson; Axel Bohring; Helmuth-Guenther Dörr; Andreas Dufke; Gabrielle Gillessen-Kaesbach; Denise Horn; Rainer König; Christian P Kratz; Kerstin Kutsche; Silke Pauli; Salmo Raskin; Anita Rauch; Anne Turner; Dagmar Wieczorek; Martin Zenker
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

3.  Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations.

Authors:  Tahir Atik; Ayca Aykut; Filiz Hazan; Huseyin Onay; Damla Goksen; Sukran Darcan; Ajlan Tukun; Ferda Ozkinay
Journal:  Indian J Pediatr       Date:  2016-01-28       Impact factor: 1.967

4.  Clinical and molecular spectra of BRAF-associated RASopathy.

Authors:  Yena Lee; Yunha Choi; Go Hun Seo; Gu-Hwan Kim; In Hee Choi; Changwon Keum; Jung Min Ko; Chong Kun Cheon; Jihyun Jeon; Jin-Ho Choi; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2020-10-10       Impact factor: 3.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.